Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1737-1743

  De Lorenzo, Mariana S ^a,b   Farina, Hernan G ^a   Alonso, Daniel F ^a   Gomez, Daniel E ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Antiestrogens; Metalloproteinases; Nafoxidine

Indexed keywords

ANTIESTROGEN; BISINDOLYLMALEIMIDE; CYCLIC AMP DERIVATIVE; ISOBUTYLMETHYLXANTHINE; METALLOPROTEINASE; METALLOPROTEINASE 2; NAFOXIDINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL SPREADING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 2; NAFOXIDINE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UMBILICAL VEINS;

EID: 3242731350     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Folkman J: Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 29: 10-36, 1985.
2. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
3. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK and Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91: 755-763, 1995.
4. Losordo DW and Isner JM: Estrogen and angiogenesis. Arterioscler Thromb Vasc Biol 21: 6-12, 2001.
5. Mendelsohn ME and Karas RH: Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811, 1999.
6. Venkov CD, Rankin A and Vaughan DE: Identification of authentic estrogen receptor in cultured endothelial cells. Circulation 94: 727-733, 1996.
7. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM and Losordo DW: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: estradiol as a survivor factor. Circulation 18: 1505-1514, 1997.
8. Cho MM, Ziats NP, Abdul-Karim FW, Pal D, Goldfarb J, Utian WH and Gorodeski GI: Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells. J Soc Gynecol Invest 5: 260-270, 1998.
9. Weiss DJ and Gurpide E: Non-genomic effects of estrogens and antiestrogens. J Steroid Biochem 31: 671-676, 1988.
10. Gagliardi A and Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 53: 533-535, 1993.
11. Gagliardi AR, Henning B and Collins DC: Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res 16: 1101-1106, 1996.
12. Sutherland RL, Watts CK and Ruenitz PC: Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylene with high affinity for the estrogen receptor. Biochem Biophy Res Comm 140: 523-529, 1986.
13. De Lorenzo MS, Alonso DF and Gomez DE: Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells. Anticancer Res 20: 395-400, 2000.
14. De Lorenzo MS, Lorenzano Menna P, Alonso DF and Gomez DE: In vitro activity of a Solanum tuberosum extract against mammary carcinoma cells. Planta Med 67: 164-166, 2001.
15. Tawil NJ, Gowri V, Djoneidi M, Nip J, Carbonetto S and Brodt P: Integrin α3β1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int J Cancer 66: 703-710, 1996.
16. Ladeda V, Aguirre Ghiso JA and Bal de Kier Joffe E: Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells. Exp Cell Res 242: 515-527, 1998.
17. Alonso DF, Tejera AM, Farías EF, Bal de Kier Joffé E and Gomez DE: Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428. Anticancer Res 18: 4499-4504, 1998.
18. De Lorenzo MS, Ripoll GV, Yoshiji H, Yamazaki M, Thorgeirsson UP, Alonso DF and Gomez DE: Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1. In Vivo 17: 45-50, 2003.
19. Short SM, Talbott GA and Juliano RL: Integrin-mediated signaling events in human endothelial cells. Mol Biol Cell 9: 1969-1980, 1998.
20. Hyder SM, Nawaz Z, Chiappetta C and Stancel GM: Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60: 3183-3190, 2000.
21. Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D, Murohara T, Principe N, Isner JM and Losordo DW: Divergence of angiogenic and vascular permeability signaling by VEGF. Inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22: 901-906, 2002.
22. Shizukuda Y, Tang S, Yokota R and Ware JA: Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C d activity. Cir Res 85: 247-256, 1999.
23. Xia P, Aiello LP, Ishii H, Jiang ZP, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR and King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996.
24. Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Tsujinoue H, Nakatani T, Shibuya M and Fukui H: Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res 59: 4413-4418, 1999.
25. Wang A, Nomura M, Patan S and Ware JA: Inhibition of protein kinase C a prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo. Circ Res 90: 609-616, 2002.
26. Tsopanoglou NE, Pipili-Synetos E and Maragoudakis ME: Protein kinase C involvement in the regulation of angiogenesis. J Vasc Res 30: 202-208, 1993.
27. Mason JC, Yarwood H, Sugars K and Haskard DO: Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC action. Am J Physiol 273: 1233-1240, 1997.
28. Foda HD, George S, Conner C, Drews M, Tompkins DC and Zucker S: Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 74: 538-545, 1996.
29. Goekjian PG and Jirousek MR: Protein kinase C inhibitors as novel anticancer drugs. Expert Opin Investig Drugs 10: 2117-2140, 2001.
30. Genersch E, Hayess K, Neuenfeld Y and Haller H: Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and-independent pathways. J Cell Sci 113: 4319-4330, 2000.
31. Zhou Y, Watters JJ and Dorsa DM: Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137: 2163-2166, 1996.
32. Moss RL, Gu Q And Wong M: Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res 52: 33-69, 1997.
33. Cid MC, Schnaper HW and Kleinman HK: Estrogens and the vascular endothelium. Ann N Y Acad Sci 966: 143-157, 2002.
34. Takahashi S, Ho A, Nagino M, Mori Y, Xie B and Nagase H: Cyclic adenosine 3', 5'-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts. J Biol Chem 266: 19894-19899, 1991.
35. Peracchia F, Tamburro A, Prontera C, Mariani B and Rotilio D: cAMP involvement in the expression of MMP-2 and MT-MMP-1 metalloproteinases in human endothelial cells. Arterioscler Throm Vas Biol 17: 3185-3190, 1997.
36. Kräling BM, Wiederschain DG, Boehm T, Rehn M, Mulliken JB and Moses MA: The role of metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sc 112: 1599-1609, 1999.